Disease | multiple myeloma |
Phenotype | C0376545|hematologic cancer |
Sentences | 1 |
PubMedID- 24249729 | Melphalan (mel) is widely used to treat patients with hematologic cancer, including multiple myeloma, but its mechanism of action in ebv-transformed b cells is poorly described. |
Page: 1